Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid.
van Gelder T, Tedesco Silva H, de Fijter JW, Budde K, Kuypers D, Arns W, Soulillou JP, Kanellis J, Zelvys A, Ekberg H, Holzer H, Rostaing L, Mamelok RD.
van Gelder T, et al. Among authors: holzer h.
Transplantation. 2010 Mar 15;89(5):595-9. doi: 10.1097/TP.0b013e3181ca7d84.
Transplantation. 2010.
PMID: 20124953
Clinical Trial.